SCHEDULE: T. Rowe Price Boosts Wingstop Stake to 7.7%
Beneficial Ownership Report
T. Rowe Price Associates, Inc. has disclosed a 7.7% beneficial ownership stake in Wingstop Inc. common stock.
Summary
- T. Rowe Price Associates, Inc. reported beneficial ownership of 2,153,306 shares of Wingstop Inc. common stock.
- This ownership represents 7.7% of Wingstop Inc.'s outstanding common stock.
- T. Rowe Price Associates, Inc. holds sole voting power over 2,064,255 shares and sole dispositive power over 2,140,877 shares.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously filed statement.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Wingstop Inc.
Sentiment
Score: 5
Explanation: This filing is a factual disclosure of beneficial ownership by an institutional investor and does not contain operational or financial performance data to assess sentiment regarding the company's business.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Wingstop Inc.'s future performance or operations.
Management Comments
- T. Rowe Price Associates, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing reflects an institutional investor's position in a publicly traded company within the restaurant industry, indicating T. Rowe Price's investment allocation decisions.
Stakeholder Impact
- Shareholders: Disclosure of a significant institutional investor's stake provides transparency regarding the company's ownership structure and may influence investor perception.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/14/2025 | Signature date of the filing |
Keywords
Wingstop, T. Rowe Price, Beneficial Ownership, Schedule 13G, Institutional Investor, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.